Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 21, 2025, 3:40 PM
0.64
0.00%
After-hours: Aug 21, 2025, 03:40 PM EDT
Brainstorm Cell Therapeutics Revenue
Brainstorm Cell Therapeutics reported an annual revenue of $849K, reflecting a 0% growth. For the quarter ending June 30, 2025, Brainstorm Cell Therapeutics generated $0 in revenue.
Revenue (ttm)
849K
Revenue Growth
n/a
Price / Sales Ratio
14.2
Revenue / Employee
31.44K
Employees
27
Market Cap
6.3M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 849K | +Infinity% |
Dec 31, 2023 | 0 | n/a |
Dec 31, 2022 | 0 | n/a |
Dec 31, 2021 | 0 | n/a |
Dec 31, 2020 | 0 | +-100.00% |
Dec 31, 2019 | -366K | -Infinity% |
Dec 31, 2018 | 0 | n/a |
Dec 31, 2017 | 0 | n/a |
Dec 31, 2016 | 0 | n/a |
Dec 31, 2015 | 0 | n/a |
Dec 31, 2014 | 0 | n/a |
Dec 31, 2013 | 0 | n/a |
Dec 31, 2012 | 0 | n/a |
Dec 31, 2011 | 0 | n/a |
Dec 31, 2010 | 0 | n/a |
Dec 31, 2009 | 0 | n/a |
Dec 31, 2008 | 0 | n/a |
Dec 31, 2007 | 0 | n/a |
Dec 31, 2006 | 0 | n/a |
Mar 31, 2005 | 0 | n/a |
Mar 31, 2004 | 0 | -100.00% |
Mar 31, 2003 | 82.89K | +261.96% |
Mar 31, 2002 | 22.9K | n/a |